Abstract
Most head and neck cancers (73% in the United States) are now related to human papillomavirus infection rather than tobacco and alcohol. Primary cancers are largely squamous-cell cancers, but combined treatment is resulting in long-term survival for most patients.
Keywords
MedicineHead and neckHuman papillomavirusHead and neck cancerSquamous cell cancerCancerOncologyInternal medicineSurgery
MeSH Terms
Antineoplastic AgentsChemoradiotherapyHead and Neck NeoplasmsHumansNeoplasm StagingPapillomavirus InfectionsPrognosis
Affiliated Institutions
Related Publications
Photodynamic therapy and the treatment of head and neck neoplasia
Abstract Objective : To present the theory, technique, and results of photodynamic therapy for the treatment of oral, laryngeal, and head and neck cancers. Study Design : Retros...
Concomitant cisplatin chemotherapy and radiotherapy in advanced mucosal squamous cell carcinoma of the head and neck. Long-term results of the radiation therapy oncology group study 81-17
One hundred twenty-four eligible patients with advanced mucosal squamous cell carcinoma of the head and neck were entered into a pilot study of concomitant cisplatin (100 mg/m2 ...
Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: Review and meta‐analysis
Abstract Human papillomavirus (HPV) has been associated with head and neck squamous cell carcinomas (HNSCC), especially of the oropharynx, with highest distribution in the tonsi...
Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study
There are few effective treatment options for patients with recurrent or metastatic head-and-neck squamous cell carcinoma. Pembrolizumab showed antitumour activity and manageabl...
An Intergroup Phase III Comparison of Standard Radiation Therapy and Two Schedules of Concurrent Chemoradiotherapy in Patients With Unresectable Squamous Cell Head and Neck Cancer
Purpose: The Head and Neck Intergroup conducted a phase III randomized trial to test the benefit of adding chemotherapy to radiation in patients with unresectable squamous cell ...
Publication Info
- Year
- 2020
- Type
- review
- Volume
- 382
- Issue
- 1
- Pages
- 60-72
- Citations
- 1842
- Access
- Closed
External Links
Social Impact
Altmetric
PlumX Metrics
Social media, news, blog, policy document mentions
Citation Metrics
1842
OpenAlex
2
Influential
1626
CrossRef
Cite This
Laura Q.M. Chow
(2020).
Head and Neck Cancer.
New England Journal of Medicine
, 382
(1)
, 60-72.
https://doi.org/10.1056/nejmra1715715
Identifiers
- DOI
- 10.1056/nejmra1715715
- PMID
- 31893516